accepting new patients

Dr. Rafael Bejar, MD, PhD, is board-certified in internal medicine, oncology, and hematology, with a special interest in hematologic malignancies (blood cancers). He specializes in the care of patients with myelodysplastic syndromes (MDS) and related blood disorders. Dr. Bejar has established a MDS Center of Excellence at UC San Diego Health focused on providing the best diagnostic tools, supportive care, clinical trials, and medical expertise in one center. Dr. Bejar is a physician scientist who in addition to caring for patients, runs a research laboratory dedicated to the study of MDS. His

Dr. Abel received his MD and MPH from Columbia University in 2000. He completed his postgraduate training in internal medicine at Massachusetts General Hospital and his hematology/oncology fellowship at Dana-Farber Cancer Institute. In 2007, he joined Dana-Farber and is a member of the Hematologic Malignancies staff, as well as the Center for Outcomes and Policy Research.

Dr. Abdel-Wahab is a hematologist/oncologist who specializes in the research and treatment of patients with a variety of myeloid malignancies, which include myeloproliferative neoplasms, myelodysplastic syndromes, and acute myeloid leukemia.

Dr. Jodi Mayfield is an Assistant Professor of Pediatric Hematology/Oncology and Stem Cell research at the University of New Mexico. She received her MD from the University of New Mexico Health Sciences Center in 2008. She is currently a member of the American Society of Hematology and the Children's Oncology Group. Dr. Mayfield's areas of practice include Stem Cell transplantation, Acute Leukemias, and Bone Marrow failure in Children. Publications Pinto N*, Mayfield JR*, Raca G, et al. Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin

Dr. Katherine Calvo is a hematopathologist and researcher in the Hematology Section Clinical Center’s Department of Laboratory Medicine at the National Institutes of Health. Dr. Calvo graduated from the University of California, San Diego School of Medicine and completed a fellowship and residency at National Institutes of Health. In collaboration with Dr. Steven Holland in the National Institute for Allergy and Infection Diseases and Dr. Neal Young from the National Heart, Lung, and Blood Institute, they have developed a method for identifying patients with a high likelihood of having GATA2

Dr Deauna-Limayo received her medical degree at the University of Santo Tomas in the Philippines. She completed her residency in Internal Medicine at the University of Southern California and fellowship in Hematology/Oncology at the University of Kansas. After fellowship, she stayed on at the University of Kansas as a teaching faculty for 18 years. She was an Associate Professor in Internal Medicine, the Director of the Lymphoma and Myeloma programs, and the chairperson for the Education Committee for Cancer Programs. She was also a member of the bone marrow transplant team. She now works at

Dr. Ellen Friedman has been the Hematology Fellowship Director of Montefiore Medical Center/Albert Einstein College of Medicine since 2005. She completed a fellowship in hematology at New York University, specializing in the conditions of red cells, platelets and hematologic malignancies. She has been engaged in diagnosing and treating these conditions while simultaneously teaching medical students, medical residents and fellows in the skills and knowledge required. She has 40 years of experience in caring for patients in the Bronx both in the city hospitals and at Montefiore/Albert Einstein